Is there a higher risk of a complicated course of hepatitis A in kidney transplant patients?

Hanssen, D A T; Dackus, J; Posthouwer, D; Vennema, H; van Loo, I H M

Hanssen, D A T; Dackus, J; Posthouwer, D; Vennema, H; van Loo, I H M.

Affiliation

Hanssen DAT; Department of Medical Microbiology, Maastricht University Medical Center, the Netherlands.
Dackus J; Department of Medical Microbiology, Maastricht University Medical Center, the Netherlands.
Posthouwer D; Department of Medical Microbiology, Maastricht University Medical Center, the Netherlands; Department of Internal Medicine, MUMC, Maastricht University Medical Center, the Netherlands.
Vennema H; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
van Loo IHM; Department of Medical Microbiology, Maastricht University Medical Center, the Netherlands. Electronic address: IHM.van.Loo@mumc.nl.

J Clin Virol ; 131: 104610, 2020 10.

Article in En | MEDLINE | ID: mdl-32871544

Subject(s)

Hepatitis A/complications; Kidney Transplantation; Hepatitis A/virology; Hepatitis A virus/immunology; Hepatitis A virus/isolation & purification; Humans; Renal Dialysis/statistics & numerical data; Risk Factors; Seroepidemiologic Studies; Time-to-Treatment; Transplant Recipients; Virus Shedding

Key words

Fulminant hepatitis; Hepatitis A; Immunity; Kidney transplant recipient; Solid organ transplant recipient

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Hepatitis A Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Clin Virol Journal subject: VIROLOGIA Year: 2020 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google